Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Dr. Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Institut Pasteur Algérie, Algeria

Author Profile

🎓 Early Academic Pursuits

Dr. Tahar Kernif’s academic journey began in 2004 when he completed his Doctorate in Veterinary Science at the École Nationale Vétérinaire d’Alger, where he conducted a comparative study on treatments for canine Leishmaniasis. This research laid the foundation for his future work in veterinary parasitology. Dr. Kernif then pursued a Magistère in Parasitology at the same institution, focusing on zoonotic diseases and vectors, which further honed his expertise in vector-borne infections. These early academic achievements earned him distinction and sparked his lifelong commitment to studying infectious diseases.

🧑‍🔬 Professional Endeavors

Since 2013, Dr. Kernif has been a Maître de Recherche at the Institut Pasteur d’Alger, where he works on molecular techniques to study parasitic diseases in veterinary science. His research focuses on Protozoa, Helminths, and the molecular ecology of arthropod vectors. He has played an integral role in shaping the institute’s research activities on infectious diseases and environmental health, contributing to key initiatives in the field of veterinary parasitology. Dr. Kernif’s professional work is also marked by collaborations with international research institutions such as CIRAD and IRD, where he has worked on studying arthropod microbiota through meta-proteomics.

🔬 Contributions and Research Focus

Dr. Kernif’s primary research interests lie in Infectious Diseases and Health and Environment, specifically focusing on multi-omics approaches to understanding pathogen behavior. His work spans genomics, metagenomics, and proteomics, applying these techniques to study diseases like leishmaniasis and tick-borne infections. His research includes phylogenetic analysis and bioinformatic modeling, which have contributed significantly to the molecular understanding of parasite-host interactions, providing insights into disease transmission and control strategies.

🌍 Impact and Influence

Dr. Kernif’s contributions extend beyond research, as he is actively involved in national health policy and scientific review boards. He served as associate editor for New Microbes and New Infections and has been a scientific examiner for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His work has shaped policies related to biodiversity and environmental health, especially in Algeria, where he is part of the National Expert Working Group for the Libreville Declaration on Health and Environment. His influence on public health and policy is a testament to his broad impact in both scientific and governmental circles.

📚 Academic Cites

Dr. Kernif has authored 35 international publications and contributed to two book chapters, demonstrating his prominent role in infectious disease research. His studies are frequently cited in scientific journals, reflecting his influence in veterinary parasitology and zoonotic diseases. His work in molecular epidemiology and vector-borne pathogens has made a lasting impact on the field and continues to guide contemporary research.

🛠️ Technical Skills

Dr. Kernif is highly proficient in a range of advanced techniques critical to research in parasitology and microbiology. His expertise spans capillary sequencing, next-generation sequencing (NGS), and PCR/qPCR, which are essential for molecular surveillance and unraveling genetic information. He is also skilled in MALDI-TOF Mass Spectrometry, currently in progress, allowing for detailed molecular analysis of pathogens. Additionally, Dr. Kernif utilizes bioinformatics to analyze complex datasets, helping to interpret vast amounts of biological data. His proficiency in meta-proteomics is instrumental in studying the microbiota of arthropods, providing insights into disease mechanisms and transmission. These tools equip Dr. Kernif with the ability to conduct precise and impactful research, advancing our understanding of infectious diseases.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Kernif has shared his expertise through academic mentorship and scientific training. As a researcher at the Institut Pasteur d’Alger, he supervises graduate students and engages in international collaborations to promote knowledge exchange. His teaching and mentorship in the field of veterinary parasitology and infectious diseases continue to shape the next generation of scientists.

🌱 Legacy and Future Contributions

Dr. Kernif’s legacy is marked by his scientific publications, international collaborations, and his influence in shaping research policy in infectious diseases. Moving forward, his research is poised to address emerging health threats, particularly those arising from vector-borne diseases. His continued contributions to global health initiatives and his work on disease surveillance are expected to leave a lasting mark on the fields of veterinary entomology and infectious disease control.

 

📖 Top Noted Publications

Update on tick-borne rickettsioses around the world: a geographic approach
    • Authors: P Parola, CD Paddock, C Socolovschi, MB Labruna, O Medianikov, …
    • Journal: Clinical Microbiology Reviews
    • Year: 2013
Borrelia, Rickettsia, and Ehrlichia species in bat ticks, France, 2010
    • Authors: C Socolovschi, T Kernif, D Raoult, P Parola
    • Journal: Emerging Infectious Diseases
    • Year: 2012
Matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid identification of tick vectors
    • Authors: A Yssouf, C Flaudrops, R Drali, T Kernif, C Socolovschi, JM Berenger, …
    • Journal: Journal of Clinical Microbiology
    • Year: 2013
Identification of flea species using MALDI-TOF/MS
    • Authors: A Yssouf, C Socolovschi, H Leulmi, T Kernif, I Bitam, G Audoly, L Almeras, …
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2014
Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France
    • Authors: C Socolovschi, P Reynaud, T Kernif, D Raoult, P Parola
    • Journal: Ticks and Tick-Borne Diseases
    • Year: 2012

farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Åbo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

💼 Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

📖Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Zubair Ahmed – HealthCare – Best Researcher Award

Prof Dr Zubair Ahmed - HealthCare - Best Researcher Award 

University of Maryland - United States

Author Profile

Early Academic Pursuits

Prof Dr Zubair M. Ahmed began his academic journey with a B.Sc. in Medical Laboratory Technology from the University of the Punjab, Lahore, Pakistan, in 1995. He continued his education, obtaining an M.Sc. in Biological Sciences from Quaid-i-Azam University, Islamabad, Pakistan, in 1998. Dr. Ahmed completed his formal education with a Ph.D. in Molecular Genetics from the National Centre for Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan, in 2002. His doctoral thesis focused on the "Genetic and Molecular Basis of Syndromic Deafness," under the guidance of Drs. Tayyab Husnain and Farhat Zaheer.

Professional Endeavors

Prof Dr . Ahmed embarked on a series of postgraduate training and fellowships in the field of Molecular Genetics. Notably, he served as a Pre-doctoral Fellow and later as a Research Fellow at the Laboratory of Molecular Genetics, National Institute of Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), Rockville, MD, USA. His expertise in molecular genetics expanded through various additional trainings, including those in protein expression, cell culture, and embryonic stem cell manipulation.

Contributions and Research Focus

Throughout his career, Prof Dr . Ahmed made significant contributions to academia and research. His expertise in molecular genetics and dedication to understanding syndromic deafness marked his early research. Noteworthy is his focus on mouse embryonic stem cells manipulation and participation in transcriptome analysis workshops. His research extended to roles as an Adjunct Assistant Professor at the National Center of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan, and later as an Assistant Professor in various divisions and departments at the University of Cincinnati, Cincinnati, OH, USA.

Accolades and Recognition

Prof Dr . Ahmed garnered several honors and awards, including the NIH Fellow Award for Research Excellence, the Third World Academy of Science Prize in Biology, and the Medal of Honor (Tamgha-i-Imtiaz) from the President of Pakistan. His contributions were further recognized with the Career Development Award from the Research to Prevent Blindness Foundation and the Maryland Innovation Initiative Award.

Impact and Influence

With a diverse academic and professional background, Prof Dr . Ahmed's impact extends beyond research to various administrative roles. His memberships in professional societies, editorial board positions, and service on committees showcase his commitment to advancing scientific knowledge and fostering academic development.

Legacy and Future Contributions

Prof Dr . Ahmed's legacy lies in his extensive academic appointments, tenured positions, and professorships at renowned institutions. As a tenured Professor in the Department of Otorhinolaryngology Head & Neck Surgery at the University of Maryland School of Medicine, he continues to contribute to the field. His role as a Senior Member of the School of Medicine Research Council reflects a commitment to shaping the future of research and education in his domain. With ongoing memberships, editorial roles, and participation in research study sections, Dr. Ahmed's influence remains impactful, with future contributions anticipated.

Notable Publication